British Homoeopathic Journal最新文献

英文中文

International conference: Patients in the history of homeopathy; Stuttgart, Germany, 30 June–3 July 1999 国际会议:顺势疗法史上的患者;1999年6月30日至7月3日，德国斯图加特

British Homoeopathic Journal

Pub Date : 2000-07-01 DOI: 10.1054/homp.1999.0408

EO Ruendal

引用次数: 1

The effect of Ecballum elatherium juice and its homeopathic dilutions on oxidative bursts of human polymorph neutrophils 槲寄生汁及其顺势稀释剂对人多形态中性粒细胞氧化爆发的影响

British Homoeopathic Journal

Pub Date : 2000-07-01 DOI: 10.1054/homp.1999.0402

M Chirila , A Olinescu

Objective The aim of this study was evaluation of the effect of juice obtained from Ecballum elatherium on the for-mation and release of the reactive oxygen intermedi-ates (ROI) in vitro by stimulated human Polymorph Neutrophils (PMNs) measured using luninol depen-dent chemiluminiscence.

引用次数: 2

Anomalies in the anomalous: last gasp or light at last? 异常中的异常:最后的喘息还是最后的光明?

British Homoeopathic Journal

Pub Date : 2000-07-01 DOI: 10.1054/homp.1999.0419

WB Jonas

引用次数: 2

International integrative primary care outcomes study (IIPCOS-2): an international research project of homeopathy in primary care 国际综合初级保健结果研究(IIPCOS-2):顺势疗法在初级保健中的国际研究项目

British Homoeopathic Journal

Pub Date : 2000-07-01 DOI: 10.1054/homp.1999.0372

M Heger , DSM Haidvogl

Objective: The primary objective is to evaluate the effectiveness of homeopathic treatment compared to conventional treatment for respiratory and ear complaints commonly seen in the primary care setting: runny nose, sore throat, ear pain, sinus pain, and cough.

Method: This study is an international, multi-center, prospective, outcomes study on the effectiveness of homeopathic treatment compared to conventional treatment. The participating investigators will be divided into three groups:

•
Homeopathic treatment;
•
Homeopathic or conventional treatment according to the patient’s preference, either randomized or non-randomized;
•
Conventional treatment.

A total of 2400 patients will be recruited. Consecutive patients, age one month or older, presenting with one of the five chief complaints, and onset of symptoms less than seven days will be included into the study. Prior to enrolment into the trial each patient must provide written informed consent. Patient outcome will be measured using the Integrative Medicine Outcomes Scale (IMOS) at 7-, 14- and 28-d telephone follow-up. In addition, covariate data related to the following will be collected: patient demographics and medical history, patient preference for treatment and willingness to be randomized, health-related quality of life, primary treatment and adjunctive therapies prescribed, adverse events, type and length of consultation, follow-up recommendation, patient compliance, patient satisfaction with treatment, and patient willingness to choose therapy and health care provider again. The main outcome criterion will be the response rate according to the IMOS after 14 days of treatment.

Results: Preliminary interim results will be presented.

Conclusions: Lessons learned from the study will be discussed.

目的:本研究的主要目的是评估顺势疗法治疗与常规治疗相比的有效性，以治疗在初级保健环境中常见的呼吸道和耳部疾病:流鼻涕、喉咙痛、耳痛、鼻窦痛和咳嗽。方法:本研究是一项国际、多中心、前瞻性、结果研究，比较顺势疗法治疗与常规治疗的有效性。参与调查者将被分为三组:•顺势疗法治疗;•顺势疗法或传统治疗根据患者的偏好，随机或非随机;•传统治疗。总共将招募2400名患者。年龄≥1个月、出现5种主诉之一且症状发作时间少于7天的连续患者将纳入研究。在参加试验之前，每位患者必须提供书面知情同意。在7、14和28天的电话随访中，使用综合医学结果量表(IMOS)测量患者的结果。此外，将收集与以下相关的协变量数据:患者人口统计学和病史、患者对治疗的偏好和随机化的意愿、健康相关的生活质量、规定的主要治疗和辅助治疗、不良事件、咨询的类型和时间、随访建议、患者依从性、患者对治疗的满意度以及患者再次选择治疗和卫生保健提供者的意愿。主要结局标准为治疗14天后IMOS的缓解率。结果:将公布初步中期结果。结论:将讨论从研究中得到的经验教训。

{"title":"International integrative primary care outcomes study (IIPCOS-2): an international research project of homeopathy in primary care","authors":"M Heger , DSM Haidvogl","doi":"10.1054/homp.1999.0372","DOIUrl":"10.1054/homp.1999.0372","url":null,"abstract":"<div>Objective: The primary objective is to evaluate the effectiveness of homeopathic treatment compared to conventional treatment for respiratory and ear complaints commonly seen in the primary care setting: runny nose, sore throat, ear pain, sinus pain, and cough.Method: This study is an international, multi-center, prospective, outcomes study on the effectiveness of homeopathic treatment compared to conventional treatment. The participating investigators will be divided into three groups:<ul><li>•Homeopathic treatment;</li><li>•Homeopathic or conventional treatment according to the patient’s preference, either randomized or non-randomized;</li><li>•Conventional treatment.</li></ul>A total of 2400 patients will be recruited. Consecutive patients, age one month or older, presenting with one of the five chief complaints, and onset of symptoms less than seven days will be included into the study. Prior to enrolment into the trial each patient must provide written informed consent. Patient outcome will be measured using the Integrative Medicine Outcomes Scale (IMOS) at 7-, 14- and 28-d telephone follow-up. In addition, covariate data related to the following will be collected: patient demographics and medical history, patient preference for treatment and willingness to be randomized, health-related quality of life, primary treatment and adjunctive therapies prescribed, adverse events, type and length of consultation, follow-up recommendation, patient compliance, patient satisfaction with treatment, and patient willingness to choose therapy and health care provider again. The main outcome criterion will be the response rate according to the IMOS after 14 days of treatment.Results: Preliminary interim results will be presented.Conclusions: Lessons learned from the study will be discussed.</div>","PeriodicalId":100201,"journal":{"name":"British Homoeopathic Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/homp.1999.0372","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21778693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 23

Effectiveness of homeopathic treatment 顺势疗法治疗的有效性

British Homoeopathic Journal

Pub Date : 2000-07-01 DOI: 10.1054/homp.1999.0393

A Brenes-Valverde

Selection of ten criteria: non-exclusive categories were considered (clinical, pathological, epidemiological, economic and social). The criteria were applied for the clinical domains of medical consultation and homeopathic therapy. Testing the criteria: a scale of three binomial categories was used. `Best' (B) was given 8 ± 10 points, and is the most important group to develop clinical research; `Acceptable' (A), with 5 ± 7 points, is considered to be of moderate importance; `Low' (L), with 1 ± 4 points, is of least importance. The criteria values were one point when predominantly present and zero point if predominantly absent.

引用次数: 2

A meta-analysis of the homeopathic treatment of pollinosis with Galphimia glauca 顺势疗法治疗花粉症伴青光眼的荟萃分析

British Homoeopathic Journal

Pub Date : 2000-07-01 DOI: 10.1054/homp.1999.0391

ML Wiesenauer , R Ludtke

OBJECTIVE1) To assess the efficacy of homeopathic prepared Galphimia glauca compared to placebo in the treatment of pollinosis. 2) To estimate the corresponding overall success rate of Galphimia glauca. Meta-analysis of clinical trials.STUDY SELECTION7 randomized double-blind placebo-controlled trials and 4 not placebo-controlled trials (1 randomized and controlled, 1 prospective uncontrolled, 2 retrospective uncontrolled) performed by our study group between 1980 and 1989. An additional MEDLINE search revealed no further trials on this topic. Exclusion and inclusion criteria were identical over all trials. In total, 1038 ambulatory patients that suffered from acute pollinosis (752 in placebo-controlled trials) entered the analysis.MAIN OUTCOME MEASURESRelative frequency and relative risk for showing noticeable and soothing relief in ocular symptoms as assessed by the patient. The overall rate of improved eye-symptoms is about 1.25 (CI: 1.09 to 1.43) times higher in the verum than in the placebo group. Verum success rate is estimated by 79.3% (CI: 74.1% to 85.0%). Across the single studies the results were highly comparable except for the study run in 1985. A significant superiority of Galphimia glauca over placebo is demonstrated. Estimates of verum success rates are comparable with those of conventional antihistaminics, but no side effects occurred. As not all of the single studies were analyzed by intention to treat analysis the results may be biased.

{"title":"A meta-analysis of the homeopathic treatment of pollinosis with Galphimia glauca","authors":"ML Wiesenauer , R Ludtke","doi":"10.1054/homp.1999.0391","DOIUrl":"https://doi.org/10.1054/homp.1999.0391","url":null,"abstract":"OBJECTIVE\u00001) To assess the efficacy of homeopathic prepared Galphimia glauca compared to placebo in the treatment of pollinosis. 2) To estimate the corresponding overall success rate of Galphimia glauca. Meta-analysis of clinical trials.\u0000\u0000\u0000STUDY SELECTION\u00007 randomized double-blind placebo-controlled trials and 4 not placebo-controlled trials (1 randomized and controlled, 1 prospective uncontrolled, 2 retrospective uncontrolled) performed by our study group between 1980 and 1989. An additional MEDLINE search revealed no further trials on this topic. Exclusion and inclusion criteria were identical over all trials. In total, 1038 ambulatory patients that suffered from acute pollinosis (752 in placebo-controlled trials) entered the analysis.\u0000\u0000\u0000MAIN OUTCOME MEASURES\u0000Relative frequency and relative risk for showing noticeable and soothing relief in ocular symptoms as assessed by the patient. The overall rate of improved eye-symptoms is about 1.25 (CI: 1.09 to 1.43) times higher in the verum than in the placebo group. Verum success rate is estimated by 79.3% (CI: 74.1% to 85.0%). Across the single studies the results were highly comparable except for the study run in 1985. A significant superiority of Galphimia glauca over placebo is demonstrated. Estimates of verum success rates are comparable with those of conventional antihistaminics, but no side effects occurred. As not all of the single studies were analyzed by intention to treat analysis the results may be biased.","PeriodicalId":100201,"journal":{"name":"British Homoeopathic Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/homp.1999.0391","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72203576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 90

An evaluation of Coffea cruda effect on rats 咖啡原料对大鼠的作用评价

British Homoeopathic Journal

Pub Date : 2000-07-01 DOI: 10.1054/homp.1999.0417

G Ruiz-Vega , L Pérez-Ordaz, P Proa-Flores, Y Aguilar-Dı́az

To investigate the effect of the homeopathic medicine Coffea cruda on sleep pattern, it was orally administered to rats at the beginning of their waking period. EEG from the parietal region was recorded during their next sleep cycle. Applying an FFT algorithm, spectral in the band, 0.5–2.5 Hz, was chosen as a marker parameter, evaluated for control and verum groups using a double-blind protocol. Power in the verum group was statistically higher than baseline value, it was not statistically different in the control group. The results indicate that an enhancement in EEG slow delta activity is associated with Coffea cruda.

为了研究顺势疗法药物克鲁达咖啡对睡眠模式的影响，我们在大鼠醒着的时候给它口服。在他们的下一个睡眠周期中记录顶叶区域的脑电图。采用FFT算法，选择0.5-2.5 Hz波段的频谱作为标记参数，采用双盲协议对对照组和verum组进行评估。verum组的权力值高于基线值，而对照组的权力值差异无统计学意义。结果表明，脑电慢波活动的增强与咖啡有关。

引用次数: 22

Dr Douglas Ronald Livingston 道格拉斯·罗纳德·利文斯顿博士

British Homoeopathic Journal

Pub Date : 2000-07-01 DOI: 10.1054/homp.1999.0409

AD Fox

引用次数: 0

Assessing the cost-effectiveness of homeopathic medicines: are the problems different from other health technologies? 评估顺势疗法药物的成本效益:问题与其他卫生技术不同吗?

British Homoeopathic Journal

Pub Date : 2000-07-01 DOI: 10.1054/homp.1999.0374

M Buxton

引用次数: 10

Improving the accessibility and quality of clinical and patient information in the patient’s medical notes 提高患者病历中临床和患者信息的可访问性和质量

British Homoeopathic Journal

Pub Date : 2000-07-01 DOI: 10.1054/homp.1999.0397

F Sharples , A van Rhijn

Objectives To improve the accessibility and quality of information in the medical notes including: the patient’s general and homeopathic history at a first consultation, the rationale for the homeopathic prescription, the evaluation of the prescription, the evaluation of the progress of the patient at follow-up visits, and the usage of conventional medication. Information needs to be accessed easily from the medical notes and needs to be of sufficient quality to be useful to clinical staff and others. This information is one source for measuring quality in clinical audit, which is an important part of the new concept of Clinical Governance which is now a requirement for British public sector hospitals. Various doctors had highlighted the difficulty in finding information easily from the notes, particularly if the patient was new to them.

引用次数: 0

首页上一页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

British Homoeopathic Journal

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀